North Carolina

Proposed rule of the Medical Board would amend regulations under 21 NCAC 32B and 32M to establish a coronavirus (Covid-19) restricted drug list and standards for physicians or physician assistants and nurse practitioners to prescribe restricted drugs for the treatment of Covid-19. The rule also would remove two drugs from the restricted drug list that is currently in effect under a temporary rule. A hearing is scheduled for Jan. 15, 2021, via teleconference. Comments are due Jan. 15, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-11-20T08:37:34-05:00November 20, 2020|North Carolina|

North Carolina

Pharmacists who need to update their immunizer status with the Board of Pharmacy to administer vaccines may find instructions here.

Also in North Carolina. The Commission for Public Health issued an emergency rule to adopt regulations under 10A NCAC 41A to require all health care providers and clinical laboratories to report all coronavirus (COVID-19) diagnostic test results, both positive and negative. The rule includes requirements for how the reporting should occur and the timeframe for reporting positive and negative results. The rule because effective on September 25 and expires November 24, 2020.

Lastly in North Carolina. The Division of Medical Assistance is extending a temporary provider rate increases including pharmacy dispensing fees through the end of the federal COVID-19 public health emergency, which goes through January 21, 2021. This action will extend all COVID-19 rate increases currently in place. For more information, please click here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-10-23T10:12:43-04:00October 23, 2020|North Carolina|

North Carolina

The Commission for Public Health announced a notice of intention to issue a temporary rule that would adopt regulations under 10A NCAC 41A to require all health care providers and clinical laboratories to report allCOVID-19 diagnostic test results, both positive and negative. The rule would include requirements for how the reporting should occur and the timeframe for reporting positive and negative results. The rule currently is in effect as an emergency rule. A hearing is scheduled for October 9 by teleconference. Comments are due October 16, 2020.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-10-09T08:14:28-04:00October 9, 2020|North Carolina|

North Carolina

In April 2020 the DEA announced its intent to deschedule Epidiolex (previously a Schedule V controlled substance). On August 21 the DEA concluded that rulemaking process.  Accordingly, under federal law, Epidiolex is no longer a controlled substance. However, for now, in North Carolina, Epidiolex remains a Schedule V controlled substance under state law.

Also in North Carolina. The next Board of Pharmacy election is scheduled to begin November 1, 2020. The Southeastern District seat presently held by J. Andrew Bowman is the only position on the Board that will be filled. Dr. Bowman will complete his first five-year term on April 30, 2021 and is eligible to run for a second term. All pharmacists actively licensed by the Board and living in North Carolina at the time of the election will be eligible to vote. Beginning November 1, 2020 pharmacists can simply log in to the Board’s Licensure Gateway and select from the list of candidates. To be eligible to run, the candidate must be an actively licensed pharmacist residing in one of the listed counties at the time of the election. Candidates who wish to stand for election will be required to submit a petition signed by ten (10) pharmacists residing in the Southeastern district to the Board office by October 1, 2020. Please contact Kristin Moore at the Board office for petition/signature logistics.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-09-11T13:41:11-04:00September 11, 2020|North Carolina|

North Carolina

For all pharmacies that have received a Cost of Dispensing Survey response request, North Carolina Medicaid has extended its Cost of Dispensing Survey deadline from August 18th to September 1st.

Also in North Carolina. The Medical Board has issued a proposed rule which would amend regulations under 21 NCAC 32S to remove the physician’s assistant’s license number and authorized primary or back-up physician’s name and telephone number from the required information in the physician assistant prescription. A hearing is scheduled for October 16, 2020, via teleconference. Comments on the proposed rule are also due on October 16, 2020.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-08-28T10:56:03-04:00August 28, 2020|North Carolina|

North Carolina

Reminder to all pharmacy and DME Permit Holders – NABP A NABP E -Profile number will be required for all 2021 renewals. Board Rule .1615 requires all pharmacy and DME permit applicants and holders to obtain and report an e-Profile number issued by the National Association of Boards of Pharmacy (NABP) as a condition of permit issuance or renewal. Details and instructions may be found here.

Also in North Carolina. The next Board of Pharmacy election is scheduled to begin November 1, 2020. One position on the Board will be filled, the Southeastern District, which is comprised of Beaufort, Bladen, Brunswick, Carteret, Columbus, Craven, Cumberland, Duplin, Greene, Harnett, Hoke, Johnston, Jones, Lenoir, New Hanover, Onslow, Pamlico, Pender, Pitt, Robeson, Sampson, Scotland, and Wayne Counties. The winner of this election will begin their term on May 1, 2021. All pharmacists actively licensed by the Board and living in North Carolina at the time of the election will be eligible to vote. Beginning November 1, 2020 pharmacists will simply log in to the Board’s Licensure Gateway and select from the list of candidates. Questions about the election or Board service in general should be directed to Jay Campbell, the Board’s Executive Director.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-07-30T15:13:52-04:00July 30, 2020|North Carolina|

North Carolina

Governor Cooper announced this week that North Carolina will continue to stay paused in the “Safer at Home Phase 2”. As a part of this initiative, the Governor’s executive order expired Friday, July 17, and has been extended for three weeks until Friday, August 7, 2020.

Also in North Carolina. The Board of Pharmacy published a temporary rule that amends regulations under 21 NCAC 46 to establish a list of restricted drugs during the coronavirus (COVID-19) public health emergency. The rule also establishes that pharmacists can fill the prescription drugs on the list only if the prescription bears a written diagnosis from the prescriber consistent with the evidence for its use. This Rule does not apply to prescriptions for a Restricted Drug for a patient previously established on that Restricted Drug on or before March 10, 2020.  The rule is effective June 26 and expires on March 23, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-07-23T13:13:49-04:00July 23, 2020|North Carolina|

North Carolina

SB 808, sponsored by Senator Harry Brown (R) has been signed by Governor Roy Cooper (D). The bill was effective upon signature and makes appropriations for the implementation of the Medicaid Transformation in the state of North Carolina. The bill also verifies Departmental receipts for the 2020-2021 fiscal year to implement the measure and also appropriates such money from the General Fund to the Department of Health and Human Services and the Division of Health benefits to be utilized for Medicaid and NC Health Choice programs to assist with projects related to Medicaid managed care.

Also in North Carolina. The North Carolina Department of Health and Human Services (NC DHHS) issued a Statewide Standing Order for Diagnostic COVID-19 Testing. State Health Director Dr. Betsey Tilson issued a statewide standing order for COVID-19 diagnostic testing as well as a temporary order and associated guidance that, among other things, requires all healthcare providers ordering or conducting COVID-19 diagnostic tests to report all results, positive or negative. NC DHHS also issued patient guidance for isolation and quarantine while waiting for, and after receiving, COVID-19 diagnostic testing results. Additional details and links can be found here.

Also in North Carolina. A qualifying military-trained or military-spouse pharmacist license or pharmacy technician applicant is exempt from the initial application fee. The state has posted FAQs that provide more detail.

Also in North Carolina. The Board of Pharmacy has posted a reminder to all pharmacy and DME permit holders that NABP E-Profile numbers will be required for 2021 renewal. Board Rule .1615 requires all pharmacy and DME permit applicants and holders to obtain and report an e-Profile number issued by the National Association of Boards of Pharmacy (NABP) as a condition of permit issuance or renewal. Details and instructions may be found here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-07-16T09:00:22-04:00July 16, 2020|North Carolina|

North Carolina

The state’s Department of Health and Human Services, Division of Medicaid Assistance has announced that Myers and Stauffer will be conducting a Cost of Dispensing Study which will be utilized to determine the dispensing fee for pharmacists for the North Carolina Medicaid program. The surveys will be mailed on July 7, 2020, and the due date is August 18, 2020.

Also in North Carolina. The General Assembly adjourned this week but will return on September 2, 2020. The adjournment resolution limits activity during the September session to COVID-19 funding issues, appointments, and veto overrides.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-07-09T23:06:50-04:00July 9, 2020|North Carolina|
Go to Top